PSNL - Personalis Inc logo

Personalis Inc

PSNL

Personalis, Inc. develops genomic tests and services for cancer diagnosis and monitoring, including liquid biopsies and tumor profiling. It supports pharmaceutical companies and clinics in personalized therapy development, biomarker discovery, and clinical trials.

โš•๏ธ Healthcare NASDAQ Listed 2019 $ USD
$1,000 invested 5 years ago โ†’$836today

Score Overview

1 Year
Score
Net Growth-31.88%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth0.03%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.3
Net Growth-64.32%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-18.51%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth-327.28%
Net Trend43%
Net Income Consistency
Rev Growth6.84%
Rev Trend71%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Personalis Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. PSNL does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 15.85โ€”
1 Year2025-10-23
$ 9.4567.72%
5 Years2021-10-22
$ 18.95-16.36%
All Time2019-06-20
$ 28.49-44.37%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 69M-$ 107M$ 212M
2025$ 69M-$ 81M$ 239M
2024$ 84M-$ 81M$ 185M
2023$ 73M-$ 108M$ 114M
2022$ 65M-$ 113M$ 167M
2021$ 85M-$ 65M$ 287M
2020$ 78M-$ 41M$ 203M
IPO2019$ 65M-$ 25M$ 128M
PSNL - Personalis Inc logo

Personalis Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 78M to $ 69M and net income went from -$ 41M to -$ 81M. Revenue increased in 3 of those 5 years; net income in 3.

Personalis Inc currently holds a 5-year HDB Score of 4.3 out of 10. How the HDB Score is calculated.

Membership

Explore PSNL with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies